|3Rodeo||California, Los Angeles, United States|
|AIB Seed Capital Fund||County Dublin, Dublin, Ireland|
|Ambit Pragma Ventures||India, Maharashtra, Mumbai|
|Array Ventures||California, San Francisco, United States|
|AT Capital Group||Central, Central Region, Singapore|
|BioLife Solutions||Bothell, United States, Washington|
|ChineseAll Digital Publishing||Beijing, Beijing, China|
|Cyberport Macro Fund (CMF)||-|
|Electronic Soul Ventures||China, Hangzhou, Zhejiang|
|Engie||France, Ile-de-France, Paris|
|Generator Ventures||California, Redwood City, United States|
|iloom||Seoul, Seoul-t'ukpyolsi, South Korea|
|Narbona Hill Corp.||California, San Francisco, United States|
|NewBornTown||Beijing, Beijing, China|
|Seed Capital Bizkaia||Bilbao, Pais Vasco, Spain|
|TD Asset Management||Canada, Ontario, Toronto|
|The Halo Group||New York, New York, United States|
|$7M||01 Nov 2022||Bengaluru, Karnataka, India|
|$28M||14 Jun 2022||Haryana, Haryana, India|
|$123M||11 Apr 2022||Faridabad, Haryana, India|
|$20M||10 Mar 2022||San Francisco, California, United States|
|$7M||08 Feb 2022||Bengaluru, Karnataka, India|
|$17M||26 Jan 2022||Jakarta, Jakarta Raya, Indonesia|
|$22M||23 Jan 2022||Bangalore, Karnataka, India|
|$10M||12 Jan 2022||Jakarta, Jakarta Raya, Indonesia|
|$4M||02 Jan 2022||Haryana, Haryana, India|
– Ultrahuman, a Bengaluru, India-based healthtech wearable glucose tracker, raised $17.5m in Series B funding.
– The round was led by Alpha Wave Incubation (AWI), Steadview Capital, Nexus Venture Partners, Blume Ventures and Utsav Somani’s iSeed fund, as well as Tiger Global’s Scott Schleifer, Sandeep Singhal, Kunal Shah, Sujeet Kumar, Deepinder Goyal, Gunjan Patidar, Gaurav Munjal, Revant Bhate, Mohit Gupta, Vikram Dhingra and Roman Saini.
– The company intends to use the funds for geographical expansion and improvement of its biomarker technology.
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.